Transpulmonary thermodilution monitoring-guided hemodynamic management improves cognitive function in patients with aneurysmal subarachnoid hemorrhage: a prospective cohort comparison

被引:4
|
作者
Ali, Achmet [1 ]
Abdullah, Taner [1 ]
Orhan-Sungur, Mukadder [1 ]
Orhun, Gunseli [1 ]
Aygun, Elif [1 ]
Aygun, Evren [1 ]
Sabanci, Pulat Akin [2 ]
Aras, Yavuz [2 ]
Akinci, Ibrahim Ozkan [1 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Anesthesiol & Reanimat, Turgut Ozal Cad, Istanbul, Turkey
[2] Istanbul Univ, Istanbul Fac Med, Dept Neurosurg, Istanbul, Turkey
关键词
Subarachnoid hemorrhage; Fluid therapy; Hemodynamic management; Cognitive function; Transpulmonary thermodilution monitor; DELAYED CEREBRAL-ISCHEMIA; NEUROGENIC PULMONARY-EDEMA; END-DIASTOLIC VOLUME; FLUID MANAGEMENT; BLOOD-VOLUME; PERFORMANCE; BALANCE;
D O I
10.1007/s00701-019-03922-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundThe effects of goal-directed hemodynamic management using transpulmonary thermodilution (TPT) monitor on the cognitive function of patients with aneurysmal subarachnoid hemorrhage (aSAH) remain unclear. The present study aimed to determine whether hemodynamic management with TPT monitor provides better cognitive function compared with standard hemodynamic management.MethodsPatients with aSAH who were admitted to the intensive care unit in 2016 were assigned to cohort 1, and those admitted in 2017 were assigned to cohort 2. In cohort 1, hemodynamic and fluid management was performed in accordance with the traditional pressure-based hemodynamic parameters and clinical examination, whereas in cohort 2, it was performed in accordance with the TPT monitor-measured flow-based parameters. The incidence of delayed cerebral ischemia (DCI) and pulmonary edema (PE) was determined. The functional outcome of patients was assessed using the modified Rankin scale (mRS) score and Montreal cognitive assessment (MoCA) test at 1year following aSAH.ResultsCohort 1 included 45 patients and cohort 2 included 39 patients who completed the trial. The incidence of DCI (38% versus 26%) and PE (11% versus 3%) was comparable between the cohorts (p>0.05). The mRS score was similar between the cohorts (p=0.11). However, the MoCA score was 20.2 (19.2-21.4) and 23.5 (22.2-24.8) in cohort 1 and cohort 2, respectively (p<0.001). Accordingly, the occurrence of poor MoCA score (38% versus 18%) was significantly lower in cohort 2 (p=0.045).ConclusionsTPT monitor-based hemodynamic management provides better cognitive outcome than standard hemodynamic management in patients with aSAH.
引用
收藏
页码:1317 / 1324
页数:8
相关论文
共 35 条
  • [21] PRESERVE: DESIGN OF A PROSPECTIVE OBSERVATIONAL COHORT STUDY TO ASSESS THE HUMANISTIC BURDEN OF DELAYED CEREBRAL ISCHEMIA IN PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE AND CAREGIVERS
    Talbot, D.
    Audibert, G.
    Bakker, T.
    Bayen, E.
    Bruder, N.
    Mayer, S.
    Puybasset, L.
    Read, S.
    Vicaut, E.
    Chalet, F. -X.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (3_SUPPL) : 171 - 172
  • [22] High-Dose Simvastatin Is Effective in Preventing Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage : A Prospective Cohort Study in Korean Patients
    Woo, Sung Woong
    Kim, Jae Hoon
    Kang, Hee In
    Kim, Deok Ryeong
    Moon, Byung Gwan
    Kim, Joo Seung
    [J]. JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2015, 58 (04) : 328 - 333
  • [23] Management of poor-grade patients with aneurysmal subarachnoid hemorrhage in the acute stage: Importance of close monitoring for neurological grade changes
    Sasaki, T
    Sato, M
    Oinuma, M
    Sakuma, J
    Suzuki, K
    Matsumoto, M
    Kodama, N
    [J]. SURGICAL NEUROLOGY, 2004, 62 (06): : 531 - 537
  • [24] Comparison of nimodipine formulations and administration techniques via enteral feeding tubes in patients with aneurysmal subarachnoid hemorrhage: A multicenter retrospective cohort study
    Mahmoud, Sherif Hanafy
    Hefny, Fatma R.
    Panos, Nicholas G.
    Delucilla, Laura
    Ngan, Zinquon
    Perreault, Marc M.
    Hamilton, Leslie A.
    Rowe, A. Shaun
    Buschur, Pamela L.
    Owusu-Guha, Jocelyn
    Almohaish, Sulaiman
    Sandler, Melissa
    Armahizer, Michael J.
    Barra, Megan E.
    Cook, Aaron M.
    Barthol, Colleen A.
    Hintze, Trager D.
    Cantin, Anna
    Traeger, Jessica
    Blunck, Joseph R.
    Shewmaker, Justin
    Burgess, Sarah V.
    Kaupp, Kristin
    Brown, Caitlin S.
    Clark, Sarah L.
    Wieruszewski, Erin D.
    Tesoro, Eljim P.
    Ammar, Abdalla A.
    Ammar, Mahmoud A.
    Binning, Mandy J.
    Naydin, Stanislav
    Fox, Neal
    Peters, David M.
    Mahmoud, Leana N.
    Keegan, Shaun P.
    Brophy, Gretchen M.
    [J]. PHARMACOTHERAPY, 2023, 43 (04): : 279 - 290
  • [25] Elevated markers of early fibrinolysis disorder as predictors of poor 90-day prognosis in patients with aneurysmal subarachnoid hemorrhage: A large prospective cohort study
    Li, Tu
    Zhang, Jun
    Li, Runting
    Lin, Fa
    Chen, Yu
    Yang, Jun
    Han, Heze
    Wang, Ke
    Jia, Yitong
    Zhao, Yang
    Wang, Shuo
    Zhao, Yuanli
    Chen, Xiaolin
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2023, 32 (12):
  • [26] The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury
    Akeret, Kevin
    Buzzi, Raphael M.
    Saxenhofer, Moritz
    Bieri, Kathrin
    Chiavi, Deborah
    Thomson, Bart R.
    Gruttner-Durmaz, Manuela
    Schwendinger, Nina
    Humar, Rok
    Regli, Luca
    van Doormaal, Tristan P. C.
    Held, Ulrike
    Keller, Emanuela
    Hugelshofer, Michael
    Schaer, Dominik J.
    [J]. BMC NEUROLOGY, 2022, 22 (01)
  • [27] The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury
    Kevin Akeret
    Raphael M. Buzzi
    Moritz Saxenhofer
    Kathrin Bieri
    Deborah Chiavi
    Bart R. Thomson
    Manuela Grüttner-Durmaz
    Nina Schwendinger
    Rok Humar
    Luca Regli
    Tristan P. C. van Doormaal
    Ulrike Held
    Emanuela Keller
    Michael Hugelshofer
    Dominik J. Schaer
    [J]. BMC Neurology, 22
  • [28] C-Terminal Proarginine Vasopressin is Associated with Disease Outcome and Mortality, but not with Delayed Cerebral Ischemia in Critically Ill Patients with an Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study
    van Oers, Jos A. H.
    Ramnarain, Dharmanand
    Oldenbeuving, Annemarie
    Vos, Piet
    Roks, Gerwin
    Kluiters, Yvette
    Beishuizen, Albertus
    de Lange, Dylan W.
    de Grooth, Harm-Jan
    Girbes, Armand R. J.
    [J]. NEUROCRITICAL CARE, 2022, 37 (03) : 678 - 688
  • [29] C-Terminal Proarginine Vasopressin is Associated with Disease Outcome and Mortality, but not with Delayed Cerebral Ischemia in Critically Ill Patients with an Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study
    Jos A. H. van Oers
    Dharmanand Ramnarain
    Annemarie Oldenbeuving
    Piet Vos
    Gerwin Roks
    Yvette Kluiters
    Albertus Beishuizen
    Dylan W. de Lange
    Harm-Jan de Grooth
    Armand R. J. Girbes
    [J]. Neurocritical Care, 2022, 37 : 678 - 688
  • [30] Relation of gray-white matter ratio with long-term cognitive functions and quality of life in patients with mild to moderate aneurysmal subarachnoid hemorrhage: a prospective observational study
    Achmet Ali
    Gamze Tanirgan
    Pulat Akin Sabanci
    Nukhet Sivrikoz
    Taner Abdullah
    Altay Sencer
    Serra Sencer
    Mukadder Orhan-Sungur
    Ibrahim Ozkan Akinci
    [J]. Acta Neurochirurgica, 2018, 160 : 181 - 189